Rick Simpson Oil (RSO) in Rhode Island: The Complete Guide by OilWell Cannabis

Understanding RSO: From Nova Scotia to the Ocean State

Who Was Rick Simpson, and Why Does He Matter to Rhode Island?

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada — about as far from Rhode Island’s shores as you can get, yet his story resonates deeply with what we’ve seen happen right here in the Ocean State. He wasn’t a doctor, scientist, or medical professional. He was a power engineer and maintenance worker, a blue-collar tradesman whose path into cannabis advocacy began not with research but with personal suffering and a deep distrust of the medical system that failed him.

In 1997, while working at a hospital in Moncton, New Brunswick, Simpson fell from a scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and a constellation of post-concussion symptoms that conventional medicine could not adequately resolve. He reported that the medications he was prescribed either failed to help or made his condition worse — a story we hear constantly from Rhode Islanders who’ve been through our workers’ compensation system after construction accidents, falls at the Port of Providence, or injuries in our state’s manufacturing plants.

When Simpson asked his physician to support or prescribe cannabis, the request was refused. Sound familiar? Rhode Island has come a long way with medical marijuana since the Edward O. Hawkins and Thomas C. Slater Medical Marijuana Act passed in 2006, but many patients still encounter doctors who dismiss cannabis as a treatment option, forcing them to seek alternatives when the system fails them.

Simpson’s interest in concentrated cannabis oil deepened after he learned about a 1974 study funded by the National Institute of Health and conducted at the Medical College of Virginia, where THC was reported to slow or shrink tumors in mice. That study became a foundational reference point in Simpson’s advocacy, even though its findings were never replicated in controlled human cancer trials.

The Moment That Started a Movement

The pivotal moment came in 2003. Simpson reported that three bumps on his arm were diagnosed as basal cell carcinoma. Rather than pursuing conventional treatment, he applied concentrated cannabis oil directly to the lesions, covered them with bandages, and waited. According to his account, the bumps disappeared within four days. No independent medical verification of this outcome has been published, and no biopsy confirmation or clinical follow-up has been documented in any peer-reviewed source. Nevertheless, this personal experience became the origin story of Rick Simpson Oil.

Important context: Simpson’s account is presented here as his personal testimony. The absence of clinical documentation, controlled observation, or independent medical confirmation means these events cannot be evaluated as medical evidence. They are, however, historically significant as the catalyst for a global movement that eventually reached Rhode Island’s shores, influencing our state’s own medical marijuana conversations and the development of products now available at our licensed compassion centers.

The Crusade: Spreading the Oil Across Borders

After his 2003 experience, Simpson committed himself to producing and distributing concentrated cannabis oil from his property in Maccan, Nova Scotia. He gave it away for free to cancer patients and others in his community, helping dozens of people with conditions including cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, and insomnia.

Simpson’s story reached a global audience through the 2005 documentary Run From The Cure, which became foundational in cannabis communities. For many Rhode Islanders, this documentary — shared through online forums, patient support groups at places like Rhode Island Hospital’s cancer centers, and word-of-mouth in our tight-knit communities — was their first introduction to the concept of concentrated cannabis oil as medicine.

Simpson’s advocacy brought him into direct conflict with Canadian law. The Royal Canadian Mounted Police raided his property in 2005 and 2009, charging him with cultivation, possession, and trafficking. He eventually left Canada for Europe. Rhode Island’s own cannabis history has seen similar tensions — from the early days of medical marijuana implementation to the recent rollout of adult-use legalization, our state has navigated the complex space between federal prohibition and state-level access.

Simpson’s Claims vs. The Evidence: What Rhode Island Patients Need to Know

Rick Simpson made expansive therapeutic claims about his oil, stating it could cure cancer and treat diabetes, chronic pain, infections, glaucoma, arthritis, depression, insomnia, multiple sclerosis, and numerous other conditions. We need to be honest with Rhode Island readers about what the science actually shows.

What Simpson was not: He had no formal training in medicine, oncology, pharmacology, or clinical research. He never conducted or published a clinical trial. His evidence was personal experience and testimonials gathered informally.

What the preclinical literature shows: In vitro studies demonstrate that THC and CBD can induce apoptosis (programmed cell death), inhibit proliferation, and reduce angiogenesis in certain cancer cell lines. Animal model studies show some tumor-growth inhibition. These findings have generated legitimate scientific interest and ongoing research at institutions like Brown University’s Center for Cannabis & Hemp Research.

What the preclinical literature does NOT show: These findings have not translated into proven human cancer cures. No human clinical trial has demonstrated that RSO or any cannabis oil preparation cures cancer. Several small human trials of cannabinoids in cancer contexts (particularly glioblastoma) have been exploratory and small, without producing results that support cancer-cure claims.

Institutional positions: The U.S. National Cancer Institute acknowledges cannabinoid anticancer research but does not endorse cannabis as cancer treatment. The FDA has not approved any cannabis plant product for cancer. Health Canada has never approved RSO for cancer. The National Center for Complementary and Integrative Health identifies the strongest evidence for epilepsy, chemo nausea, and HIV/AIDS appetite — not cancer cure.

What Simpson got right: He drew attention to cannabinoids as a serious biomedical research area when the world was ignoring it. His advocacy helped create the political and cultural conditions for the legal cannabis industry that now serves Rhode Island patients through our state-licensed compassion centers.

What he overstated: The leap from preclinical signals to cancer cure was not supported by human evidence then and is not supported now. Encouraging patients to rely on RSO as a primary cancer treatment in place of proven oncologic therapies carries genuine harm potential. Rhode Island’s oncology community — from the comprehensive cancer programs at Rhode Island Hospital to the specialized care at Miriam Hospital’s cancer center — has expressed concerns about patients delaying or foregoing evidence-based treatments.

Traditional RSO vs. Modern Formulated RSO: Why Ocean State Patients Deserve Better

The term RSO has become generic across the legal cannabis industry. Many products labeled as RSO bear little resemblance to what Simpson originally made. Here’s how OilWell’s approach specifically addresses the problems with traditional RSO that Rhode Island patients should understand:

Why OilWell’s Formulas Diverge from Traditional RSO

Our approach isn’t about rejecting Simpson’s vision — it’s about evolving it with the precision Rhode Island patients deserve:

Multi-cannabinoid approach. Traditional RSO relied on whatever single strain the maker grew. Our formulas include seven cannabinoids — CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC — because the entourage-effect literature suggests potential benefit from cannabinoid diversity, even though robust clinical proof of whole-formula synergy remains limited.

Terpene preservation and addition. Traditional RSO had essentially no terpene content. We include live terpenes at 5% with a specific seven-terpene profile — limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene — because terpene bioactivity is plausible and supported at the preclinical level.

THCa as a separate ingredient. Traditional RSO fully decarboxylated everything. Our sublingual formula includes THCa at 1,500 mg as a distinct ingredient, preserving the acidic precursor because THCa literature suggests potentially relevant non-psychoactive bioactivity.

Reduced delta-9 THC dominance. Traditional RSO was overwhelmingly delta-9 THC (60-90%). Our formula uses delta-9 THC at only 90 mg while incorporating delta-8 THC at 6,000 mg and distributing remaining cannabinoids across CBD, CBG, CBN, and CBC.

Product format innovation. Simpson envisioned only oral oil. We offer both a 30 mL sublingual oil and a 1-gram vape cartridge, each with format-specific formulations acknowledging that different delivery routes have different pharmacokinetic profiles.

The OilWell Story: Built From Real Adversity, Not Corporate Planning

From McAllen to Montrose: A Journey That Shapes How We Serve Rhode Island

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. Colin grew up in McAllen, Texas — right across the river from Reynosa, Tamaulipas, Mexico. The McAllen-Reynosa area, known as the Borderplex, is one of the most economically challenged and dangerous regions along the U.S.-Mexico border. That childhood — marked by violence, friends killed or imprisoned, leaving home at sixteen — forged a perspective that resonates with Rhode Islanders who’ve faced their own struggles, whether in our post-industrial mill towns, our fishing communities battling regulation and climate change, or our urban neighborhoods grappling with decades of systemic challenges.

Despite the dangers, Colin did not fall into the darkest paths. He focused on cannabis, seeing it as a safer and more beneficial alternative. He grew up in the traditional cannabis world long before legalization, learning the plant intimately while operating in the shadows. Over time, he transitioned from those early, risky ventures to creating a legal, legitimate business in an industry he believes in.

Colin later became a formally trained software engineer and did custom development work for Baylor College of Medicine, one of the most prestigious medical institutions in the Texas Medical Center. That combination — deep cannabis plant knowledge plus medical-grade technical precision — defines OilWell’s approach and is why we can offer Rhode Island patients the level of quality and standardization they deserve.

Bentley’s Story: The Foundation of Everything

The company’s origin story begins with a dog named Bentley. Bentley was more than just a pet — he was family. When Bentley fell seriously ill with paralysis in his back legs, veterinarians delivered the verdict no pet owner wants to hear: euthanasia was the only humane option. They said pain medications would destroy his internal organs, causing more suffering.

But giving up on Bentley was not an option. In a desperate search for alternatives, Colin stumbled upon CBD through a question that changed everything: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

Determined to save Bentley, Colin learned to create CBD golden paste. The result? Bentley got up, walked across the room, and brought his ball to play. From paralyzed and facing euthanasia to fetching his ball. This was not placebo effect — dogs do not respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, passing naturally at age twenty. During those ten years, Colin developed specialized cannabis formulas for every age-related condition Bentley faced. Neurodegeneration led him to understand CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection. Dementia led him to CBC’s role in neurogenesis. Glaucoma led him to THC’s CB1 agonism. Crippling arthritis led him to develop multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene.

Single cannabinoids were not enough. Bentley’s evolving conditions required multi-cannabinoid synergy. That decade of real-world formulation testing on a patient he loved more than anything became the foundation of the RSO formula we now offer Rhode Island.

Colin’s Personal Story: Living What Rhode Island Patients Live

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he did it cold turkey — notoriously difficult and dangerous — using the cannabinoid knowledge he developed keeping Bentley alive.

The Peace Gummies formula that became an OilWell product was created during midnight experiments while fighting through benzo withdrawal. To ensure quick relief, OilWell also offers the Peace Gummies formula in a vape form, which Colin personally uses to manage his insomnia and severe PTSD. This is not theoretical knowledge. Colin lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not.

Over time, Colin developed formulas that doctors use for conditions like Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. His focus has always been making cannabis accessible for everyone, including vegans, diabetics, and those with specific health needs.

ABC13 Media Recognition: Third-Party Validation Rhode Island Can Trust

Between September 2019 and April 2023, ABC13 Houston — the ABC affiliate serving America’s fourth-largest city — featured Colin Valencia and OilWell Cannabis in seven distinct news segments. Five different ABC13 reporters sought Colin out across those years: Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, and KTRK staff writers.

No other Houston cannabis operator appears with that frequency or across that breadth of subject matter. When ABC13 needed to explain a new cannabis product, it called Colin. When a state agency reversed course on Delta-8 legality overnight, it called Colin. When a sitting president announced marijuana pardons and the station needed someone who had personally lived with a cannabis conviction to put it in context, it called Colin.

September 15, 2019 — The Foundational Quote:

“I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

This quote from 2019 is the seed of everything OilWell would become. The open-source formula publication, the evidence-based research documentation, the refusal to make unsupported claims — it all traces back to this principle.

March 22, 2021 — The Therapy Quote:

“People think that everyone just wants to get high and it’s about giggling and things like that, and there’s nothing wrong with that. But that’s a different version of therapy, and people are looking for things to help them with real pain. Pain comes in a lot of different forms.”

May 24, 2021 — Radical Honesty:

Steve Campion asked: “Why would someone want to smoke that?” Colin’s response, aired uncensored on ABC: “I don’t give a sh** if it’s wrong to say you’ll get high off it. Maybe you want to get high.”

August 20, 2021 — Community Action:

OilWell gave away approximately $35,000 in product (1,000 caviar pre-rolls) to encourage COVID-19 vaccination, in coordination with the city of Houston. No political strings attached.

October 19, 2021 — Ethical Leadership:

When Texas DSHS classified Delta-8 as Schedule I overnight, Colin proactively removed all products before enforcement and warned other operators who were unknowingly shipping what had become Schedule I narcotics.

October 7, 2022 — Personal Stakes:

The feature revealed Colin has previously faced charges for marijuana possession. He stated: “I would love to see people not get hurt for this anymore.” This personal history transforms every other quote — every feature about therapy, education, and not selling snake oil carries additional weight when you understand the person saying it has personally experienced cannabis criminalization.

April 21, 2023 — Renaissance Framing:

“Right now is actually a pretty – like Renaissance – pretty important time that should be enjoyed now.”

These features are not marketing materials. They are independently produced, editorially controlled news segments from a major-market ABC affiliate that repeatedly identified Colin Valencia as the most credible voice in Houston’s legal cannabis industry. That recognition cannot be purchased — it can only be earned.

The OilWell RSO Philosophy: Four Pillars for Rhode Island

1. Accessibility Over Gatekeeping

No medical card is required. Anyone age twenty-one or older can purchase. We ship nationwide across the United States and internationally to customers who verify local legality. This matters profoundly for Rhode Island patients who may not qualify for our state’s medical marijuana program but still need access to high-quality cannabinoid medicine.

Simpson believed medicine should be accessible to everyone. We built a product and distribution model that makes that accessible legally.

2. Patient-Controlled Potency

THCa is sold in its acidic, non-psychoactive form. You decide whether to use it raw for non-psychoactive benefits or to decarboxylate it into delta-9 THC for full psychoactive potency. This is the single most important innovation for Rhode Island patients who need to function during the day.

Daytime use in Rhode Island: Keep THCa raw for zero impairment while working at Electric Boat, managing accounts in Downtown Providence, teaching at URI, or caring for family. The anti-inflammatory benefits remain without psychoactivity.

Evening use: Decarboxylate for full therapeutic strength when you’re home in Cranston, Warwick, or Newport and can fully relax.

Simpson believed patients should control their own medicine. We engineered a product that puts that control in your hands through chemistry rather than rhetoric.

3. Open-Source Formulas

We publish our complete formulas publicly — every cannabinoid, every milligram amount, every percentage — so that any Rhode Island resident who cannot afford our products can source ingredients and make their own version. If you’re in Woonsocket facing economic hardship, or a caregiver in Pawtucket managing multiple medical expenses, you have options.

Simpson gave his oil away for free and taught people how to make it. We adapted that ethos for the modern cannabinoid marketplace: sell a professionally manufactured, lab-tested, standardized product for those who want it, and publish the complete recipe for those who want to make it themselves.

The Bentley Recipe — Our Original Open-Source Formula:

We published the actual CBD golden paste recipe that saved Bentley’s life:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1 to 2 teaspoons freshly ground black pepper (crucial for absorption)
• CBD oil (dosage depends on size and needs; consult veterinarian)

Mix turmeric and water over low heat to form thick paste (7-10 minutes). Add coconut oil and pepper. Cool, refrigerate up to two weeks. Mix with pet’s food.

This pattern is consistent. We gave away the formula that saved Bentley before we gave away the formula for people. The open-source ethos is not a marketing strategy — it’s our foundational behavior.

4. Evidence-Informed, Not Evidence-Overstating

The research documentation in this guide represents our commitment to honest education about what the science actually says. Simpson operated without access to peer-reviewed literature. We have that access and use it to distinguish between what is well-supported, what is emerging, and what is overstated.

Farm Bill Compliance and Rhode Island Legal Framework

The 2018 Farm Bill legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC by dry weight at the federal level. This is the foundation of our RSO product design and why we can legally ship to Rhode Island.

Our RSO Sublingual Oil contains only 90 milligrams of delta-9 THC in the entire 30 mL bottle — 3 milligrams per milliliter — well under the 0.3% threshold. All cannabinoids are hemp-derived. The product is legal under federal law and in Rhode Island.

THCa Legal Distinction: THCa is the acidic, non-psychoactive precursor to delta-9 THC. It is not itself delta-9 THC, making it Farm Bill compliant at point of sale. This distinction is legally significant for Rhode Island residents.

Practical Significance: You can decarboxylate THCa into delta-9 THC at home by heating the oil at 260°F (125°C) for 45-60 minutes in an oven-safe glass container. This converts 1,500 mg of THCa into approximately 1,315 mg of delta-9 THC. Combined with the existing 90 mg of delta-9 THC, this produces approximately 1,405 mg of total delta-9 THC — giving the product psychoactive potency comparable to traditional illegal RSO, entirely at your discretion after purchase.

Rhode Island Legal Notice: THCa converts to delta-9 THC when heated. Rhode Island residents are responsible for understanding and complying with state laws regarding cannabinoid products. We ship with full documentation, Certificates of Analysis, and receipts. Rhode Island legalized adult-use cannabis in 2022, but home production regulations and possession limits apply. This product is intended for adults 21+.

The Decarboxylation Choice: Putting Rhode Island Patients in Control

Traditional RSO was always fully decarboxylated. The heat of solvent evaporation converted all THCa into delta-9 THC, leaving patients with no choice about psychoactivity.

Our sublingual formula includes 1,500 mg of THCa in its acidic, non-psychoactive form, creating three distinct usage options:

Option 1 — Raw, No Heat (Non-Psychoactive Daytime Use for Rhode Island):

• All 1,500 mg stays as THCa — completely non-psychoactive
• Potential anti-inflammatory activity via COX-2 inhibition
• Neuroprotective potential via PPARγ agonism
• Perfect for: Working at Raytheon in Portsmouth, driving through Providence rush hour, teaching in South Kingstown, caring for family in North Providence
• Zero impairment, full functionality

Option 2 — Fully Activated (Home Decarboxylation for Evening Therapeutic Use):

• Heat at 260°F for 45-60 minutes
• Converts 1,500 mg THCa → ~1,315 mg delta-9 THC
• Combined with existing 90 mg delta-9 THC = ~1,405 mg total delta-9 THC
• Plus 6,000 mg delta-8 THC = psychoactive potency comparable to traditional illegal RSO
• 100% legal — decarboxylation occurs at your discretion after purchase

Option 3 — Vape (Instant Relief for Rhode Island Patients):

• Auto-decarboxylation at 400-450°F vaping temperature
• Instant conversion with each puff
• Fastest-onset RSO delivery method available
• Perfect for: Breakthrough pain at home in Westerly, acute nausea during chemo at Rhode Island Hospital, panic attacks, unexpected flare-ups

Conversion Chemistry: THCa has a molecular weight of 358.47 g/mol. The conversion ratio is approximately 1 mg THCa = 0.877 mg delta-9 THC after decarboxylation, reflecting the loss of a CO₂ molecule during the reaction.

This design puts the potency decision entirely in your hands — aligning with Rick Simpson’s principle that patients should control their own medicine, but implementing that principle through actual product chemistry rather than a one-size-fits-all approach.

Solvent-Free Production: Rhode Island Safety Standards

Our RSO is not an extraction product in the traditional sense. It’s a formulated blend of individual cannabinoid distillates and isolates combined at specific ratios in a controlled production environment. No naphtha. No isopropyl alcohol. No butane. No extraction solvents are present in the finished product.

This eliminates the residual solvent risk that is one of the most significant safety concerns with traditional RSO production. For Rhode Island patients concerned about product purity — especially those with compromised immune systems undergoing chemotherapy at Lifespan facilities or managing chronic conditions — this matters profoundly.

Organic MCT Oil Base: We use food-grade medium-chain triglycerides as the carrier base. MCT oil facilitates cannabinoid absorption through sublingual tissue and provides a neutral taste profile — a significant improvement over the tar-like consistency and solvent-residual odor of traditional RSO.

Third-Party Lab Testing: Every batch undergoes comprehensive testing covering:

• Cannabinoid potency (verified to ±2% accuracy)
• Terpene profile
• Pesticides (400+ compound screening)
• Heavy metals (arsenic, cadmium, lead, mercury below FDA limits)
• Residual solvents (FDA Class 3 limits <5,000 ppm)
• Microbial contaminants (E. coli, Salmonella, Aspergillus)

Certificates of Analysis (COAs) are available on request and accessible through our website.

Our Complete Product Line for Rhode Island

RSO Sublingual Oil — $129.99

• 30 mL bottle (approximately 40-60 doses depending on serving size)
• 16,590 mg total cannabinoids (553 mg per mL)
• Seven cannabinoids:
  • CBD: 4,500 mg
  • CBG: 3,000 mg
  • Delta-8 THC: 6,000 mg
  • THCa: 1,500 mg (convertible to ~1,315 mg delta-9 THC)
  • Delta-9 THC: 90 mg
  • CBN: 750 mg
  • CBC: 750 mg
• Live terpenes at 5%: Limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene
• Organic MCT oil base
• Graduated dropper: 0.1 mL increments for precise dosing
• Onset: 15-45 minutes (sublingual absorption)
• Peak effects: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19%

RSO Vape Cartridge — $49.99

• 1-gram cartridge
• 900+ mg total cannabinoids
• Six-cannabinoid ratio:
  • CBD: 30%
  • CBG: 20%
  • Delta-8 THC: 15%
  • THCa: 10% (auto-decarbs at vaping temp)
  • CBN: 10%
  • CBC: 10%
• Live terpenes at 5%+
• 510-thread universal battery compatibility (works with standard vape batteries available throughout Rhode Island)
• Onset: 1-2 minutes (fastest delivery)
• Peak effects: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35%

When to Use Each Format: Rhode Island Lifestyle Guide

Competitive Comparison: Why Rhode Island Patients Choose OilWell

OilWell RSO vs. Rhode Island Dispensary RSO

OilWell RSO vs. Hemp CBD Oils in Rhode Island

Condition-Specific Usage for Rhode Island Patients

Critical Disclaimer: The following contexts are informed by cannabinoid research cited in our evidence section. They are not medical prescriptions, not FDA-approved treatment protocols, and not a substitute for professional medical care. These products have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider, especially if you have a medical condition, take medications, are pregnant or nursing, or have health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Chemotherapy-Related Nausea and Appetite Support (For Rhode Island Cancer Patients)

• Pre-chemo: 0.5-1.0 mL sublingual approximately 1 hour before treatment at Rhode Island Hospital or Miriam Hospital
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5 mL sublingual every 6 hours as needed
• Sleep support during treatment: 1.0-2.0 mL sublingual before bed (delivers 25-50 mg CBN)
• Evidence: delta-8 THC antiemetic [9], delta-9 THC nausea evidence [1][13], CBD anxiolytic buffering [3]

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy — Common in Rhode Island)

• Daytime: 0.3-0.5 mL raw sublingual — anti-inflammatory without psychoactive impairment
• Nighttime: 0.5-1.0 mL decarboxylated sublingual — combines pain relief with CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset
• Evidence: CBD pain evidence [4], delta-9 THC pain evidence [13], beta-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12]

Sleep Support (For Rhode Islanders with Insomnia)

• Before bed: 1.0-2.0 mL sublingual
• At 2.0 mL: Delivers 50 mg CBN — dosage investigated in 2024 sleep literature
• At 1.0 mL: Delivers 25 mg CBN — above threshold associated with reduced sleep disturbance
• Evidence: CBN sleep evidence [16][17], cannabis and sleep literature

Anxiety and Stress (For Rhode Island’s High-Stress Professionals)

• Daytime functional relief: 0.3 mL raw sublingual — CBD and CBG address anxiety without impairment
• Nighttime: 1.0 mL sublingual — full profile including CBN for sleep architecture
• Evidence: CBD anxiety evidence [3], CBG pharmacology [7][8], limonene entourage evidence [20]

General Titration Principle for Rhode Island

Start low, go slow. Begin with 0.25-0.5 mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and other factors. Rhode Island’s diverse population means there’s no one-size-fits-all approach.

Delivery to Rhode Island: How Ocean State Patients Get Our Products

Nationwide Shipping to Rhode Island

We ship to all Rhode Island addresses via:

• USPS Priority Mail (2-3 business days)
• FedEx/UPS Ground (3-5 business days)
• Discreet packaging with no cannabis branding visible
• Tracking provided for all orders
• Temperature-stable packaging for summer shipments to Rhode Island’s coastal climate
• Signature-required option available

Rhode Island Shipping Details

All packages include:

• Full documentation for Rhode Island compliance
• Certificates of Analysis (COAs)
• Receipts with Farm Bill compliance verification
• Discreet labeling that respects Rhode Island’s privacy-conscious culture

Rhode Island Legal Responsibility: Customers verify local legality. Rhode Island legalized adult-use cannabis in 2022, but home production regulations apply. Possession limits: up to 1 ounce of cannabis outside the home, 10 ounces at home. This product is intended for adults 21+.

International Access for Rhode Island Expats

Rhode Island natives living abroad — whether in military service, retirement, or work — can access our products internationally. The THCa legal framework makes this possible: because the product contains less than 0.3% delta-9 THC at point of sale, it meets the definition of a hemp-derived product under the 2018 Farm Bill and is shippable to jurisdictions with compatible hemp laws.

All international packages include full documentation, COAs, and receipts for customs purposes. Customers accept all customs and legal responsibility.

How Our Formulas Connect to the Evidence: Rhode Island’s Right to Know

Every cannabinoid in our formula — CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC — has its own evidence profile in our research section. Every terpene — limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene — is covered with preclinical and review-level evidence.

Our formulas are anchored to per-compound evidence summaries that explain what is well-supported by human clinical data, what is emerging, and what is overstated. We do not exempt ourselves from the same evidence standards we apply to the broader field.

The Bottom Line for Rhode Island: This is more than a brand — it’s a promise to Rhode Island patients that we will always strive to deliver the best, most thoughtful cannabis products available. We’re not here to follow trends. We’re here to set them. And as we continue to grow, our focus remains on maintaining the same level of integrity, creativity, and commitment that defined us from the day Bentley got up, walked across the room, and brought his ball to play.

Ordering Information for Rhode Island

Phone: (832) 416-2816
Email: [email protected]
Website: https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/
Instagram: @oilwellcbd

RSO Sublingual Oil: $129.99
RSO Vape Cartridge: $49.99

Available for immediate shipping to all Rhode Island cities and towns: Providence, Warwick, Cranston, Pawtucket, East Providence, Woonsocket, Newport, Central Falls, Westerly, Coventry, Cumberland, North Providence, South Kingstown, Johnston, North Kingstown, West Warwick, Smithfield, Lincoln, Portsmouth, Barrington, Middletown, Bristol, Tiverton, Narragansett, East Greenwich, North Smithfield, Warren, Scituate, Burrillville, Charlestown, Exeter, Foster, Glocester, Hopkinton, Jamestown, Little Compton, New Shoreham (Block Island), Richmond, and West Greenwich.

Business Hours: Monday-Thursday 10 AM – 7 PM CT, Friday-Saturday 10 AM – 10 PM CT, Sunday 10 AM – 4 PM CT

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Age Requirement: 21+ only.

Legal Compliance: Contains less than 0.3% delta-9 THC. Farm Bill compliant. Hemp-derived cannabinoids.

Safety Warning: May cause drowsiness or impairment. Do not operate vehicles or machinery after consuming activated (decarboxylated) product. Consult your physician before use, especially if pregnant, nursing, or taking medications. Keep out of reach of children.

Rhode Island Specific: Rhode Island legalized adult-use cannabis in 2022. Possession limits: 1 ounce outside home, 10 ounces at home. This product is intended for adults 21+. Customer responsible for compliance with Rhode Island law. Home cultivation allowed for medical patients (up to 12 plants). Not intended for resale. Buyer accepts all legal responsibility for use and decarboxylation decisions. Void where prohibited by law.